These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. COX-2 inhibition and the control of pain. Kiefer W; Dannhardt G Curr Opin Investig Drugs; 2002 Sep; 3(9):1348-58. PubMed ID: 12498012 [TBL] [Abstract][Full Text] [Related]
3. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors. Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727 [TBL] [Abstract][Full Text] [Related]
4. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors. Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938 [TBL] [Abstract][Full Text] [Related]
6. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives. Shin SS; Byun Y; Lim KM; Choi JK; Lee KW; Moh JH; Kim JK; Jeong YS; Kim JY; Choi YH; Koh HJ; Park YH; Oh YI; Noh MS; Chung S J Med Chem; 2004 Feb; 47(4):792-804. PubMed ID: 14761182 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Reddy CM; Bhat VB; Kiranmai G; Reddy MN; Reddanna P; Madyastha KM Biochem Biophys Res Commun; 2000 Nov; 277(3):599-603. PubMed ID: 11062000 [TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Kusunoki N; Yamazaki R; Kawai S Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of selective COX-2 inhibitors. Capone ML; Tacconelli S; Sciulli MG; Patrignani P Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704 [TBL] [Abstract][Full Text] [Related]
10. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS; Davis TW; Ornberg RL; Masferrer JL Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of loxoprofen and its alcohol metabolites for potency and selectivity of inhibition of cyclooxygenase-2. Riendeau D; Salem M; Styhler A; Ouellet M; Mancini JA; Li CS Bioorg Med Chem Lett; 2004 Mar; 14(5):1201-3. PubMed ID: 14980665 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological activity and molecular modeling studies of novel COX-1 inhibitors. Martić M; Tatić I; Marković S; Kujundzić N; Kostrun S Eur J Med Chem; 2004 Feb; 39(2):141-51. PubMed ID: 14987823 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme. Uddin MJ; Rao PN; McDonald R; Knaus EE Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969 [TBL] [Abstract][Full Text] [Related]
14. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase]. Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123 [TBL] [Abstract][Full Text] [Related]
15. 1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors. Biava M; Porretta GC; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Makovec F; Anzini M J Med Chem; 2005 May; 48(9):3428-32. PubMed ID: 15857149 [TBL] [Abstract][Full Text] [Related]
16. Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors. Uddin MJ; Rao PN; Knaus EE Bioorg Med Chem Lett; 2004 Apr; 14(8):1953-6. PubMed ID: 15050635 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors. Singh SK; Saibaba V; Ravikumar V; Rudrawar SV; Daga P; Rao CS; Akhila V; Hegde P; Rao YK Bioorg Med Chem; 2004 Apr; 12(8):1881-93. PubMed ID: 15051057 [TBL] [Abstract][Full Text] [Related]
18. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation. Srinath P; Rao PN; Knaus EE; Suresh MR Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors. Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648 [TBL] [Abstract][Full Text] [Related]
20. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells. Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]